Transverse myelitis: Difference between revisions

From IDWiki
(Imported from text file)
 
m (Text replacement - " species]]" to "]]")
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
== Definition ==
==Definition==


* Heterogeneous condition characterized by inflammation of the spinal cord
*Heterogeneous condition characterized by inflammation of the spinal cord


== Etiology ==
==Etiology==


*CNS disorders
* Post-infectious
**[[Multiple sclerosis]]
* Post vaccination
**[[Neuromyelitis optica]]
* Infectious
**[[Acute disseminated encephalomyelitis]] (ADEM)
** VZV
**[[Myelin oligodendrocyte glyocprotein antibody-associated disorder]]
** CMV
*Systemic inflammatory disorders
** Etc.
**[[Sarcoidosis]]
* Systemic inflammatory conditions
**[[Sjögren syndrome]]
** Sarcoidosis
**[[Systemic lupus erythematosus]]
* Acquired demyelinating disease
**Others: [[ankylosing spondylitis]], [[antiphospholipid antibody syndrome]], [[Behçet disease]], [[mixed connective tissue disease]], [[rheumatoid arthritis]], and [[systemic sclerosis]]
** MS
*Infectious
* Idiopathic
**[[Enteroviruses]], especially D68 and EV71
**[[West Nile virus]]
**[[Herpesviridae]], including [[HSV]], [[VZV]], [[EBV]], [[CMV]], and [[HHV-6]]
**[[HIV]]
**[[HTLV-1]]
**[[Zika virus]]
**[[Lyme disease]]
**[[Mycoplasma]]
**[[Treponema pallidum]]
*Paraneoplastic, most often secondary to [[small cell lung cancer]]
**Anti-Hu disease
**Anti-CRMP5 disease
*Idiopathic


== Clinical Presentation ==
==Clinical Manifestations==


*Presentation is either acute or subacute, usually starting with sensory changes, weakness, or pain
* Motor and sensory deficits
*Characterized by both motor and sensory deficits, with specific deficits depending on the spinal level of the lesion


== Investigations ==
==Investigations==


* MRI spine '''with gadolinium'''
*MRI spine '''with gadolinium''', showing characteristic T2 hyperintensity without evidence of cord compression
*CSF showing pleocytosis


== Diagnosis ==
==Diagnosis==


* Bilateral sensorimotor and autonomic spinal cord dysfunction
*Sensorimotor and autonomic spinal cord dysfunction
** May be asymmetric
**Generally bilateral but may be asymmetric
* Clearly defined sensory level
*Clearly defined sensory level
*Bilateral signs and symptoms
* Progression peaking between 4h and 21d after onset
*Progression peaking between 4h and 21d after onset
* Demonstration of spinal cord inflammation
*Demonstration of spinal cord inflammation
** Cerebrospinal fluid with pleocytosis or increased IGG
**Cerebrospinal fluid with pleocytosis or increased IGG
** MRI with gadolinium
**MRI with gadolinium
* Exclusion of compressive, postradiation, neoplastic, and vascular causes
*Exclusion of compressive, postradiation, neoplastic, and vascular causes


== Management ==
==Management==


* Determine cause
*Determine cause
* Consider high-dose steroids 1g/d x3-5 days
*Consider high-dose steroids 1g/d x3-5 days
* Thromboembolism prophylaxis
*Thromboembolism prophylaxis
* Symptom management for pain and spasticity
*Symptom management for pain and spasticity
** Muscle relaxants
**Muscle relaxants
* Rehab (PT/OT)
*Rehab (PT/OT)
* Follow-up investigations
*Follow-up investigations
** Repeat MRI
**Repeat MRI


[[Category:Neurology]]
[[Category:Neurology]]

Latest revision as of 12:53, 30 January 2022

Definition

  • Heterogeneous condition characterized by inflammation of the spinal cord

Etiology

Clinical Manifestations

  • Presentation is either acute or subacute, usually starting with sensory changes, weakness, or pain
  • Characterized by both motor and sensory deficits, with specific deficits depending on the spinal level of the lesion

Investigations

  • MRI spine with gadolinium, showing characteristic T2 hyperintensity without evidence of cord compression
  • CSF showing pleocytosis

Diagnosis

  • Sensorimotor and autonomic spinal cord dysfunction
    • Generally bilateral but may be asymmetric
  • Clearly defined sensory level
  • Bilateral signs and symptoms
  • Progression peaking between 4h and 21d after onset
  • Demonstration of spinal cord inflammation
    • Cerebrospinal fluid with pleocytosis or increased IGG
    • MRI with gadolinium
  • Exclusion of compressive, postradiation, neoplastic, and vascular causes

Management

  • Determine cause
  • Consider high-dose steroids 1g/d x3-5 days
  • Thromboembolism prophylaxis
  • Symptom management for pain and spasticity
    • Muscle relaxants
  • Rehab (PT/OT)
  • Follow-up investigations
    • Repeat MRI